V CompBrief BY VELARION

Chief Financial Officer · MapLight Therapeutics, Inc. (MPLT)

Vishwas Setia

Vishwas Setia, Chief Financial Officer of MapLight Therapeutics, Inc., received total compensation of $6,202,564 for fiscal year 2025. His disclosed compensation included a base salary of $432,294, a cash bonus of $183,000, and stock-based compensation of $5,568,117.

FY2025 is the first fiscal year CompBrief holds for Vishwas Setia as a named executive officer of MapLight Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$6,202,564

3rd of 3 named executive officers at MapLight Therapeutics by FY2025 total.

3 named officers on file for MapLight Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. MapLight Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how MapLight Therapeutics’s whole pay program stands against its peers

  • MapLight Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MPLT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Free

Get Vishwas Setia’s full pay file as a PDF — free

More than this page: up to 10 years of Vishwas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Vishwas Setia and every company like it: Velarion Intel, free for 3 days, no card →

Vishwas Setia compensation by year

MapLight Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as MapLight Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$432,294
Bonus$0
Stock awards$3,200,500
Option awards$2,367,617
Non-equity incentive$183,000
Pension and deferred compensation$0
All other$19,153
Total$6,202,564

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MapLight Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191449, and prior-year filings.

How this page was built: the MapLight Therapeutics, Inc. filed document, accession 0001193125-26-191449. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU248,513$4,365,131—
RSU72,743$1,277,731—
RSU43,367$761,741—
Option176,031—$17.00

Per the Outstanding Equity Awards at Fiscal Year-End table in MapLight Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

MapLight Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Christopher KroegerPresident and Chief Executive Officer$25,624,254
Erin FoffChief Medical Officer$6,254,000
Vishwas Setia · this pageChief Financial Officer$6,202,564

Vishwas Setia's compensation dossier, MapLight Therapeutics

You have read Vishwas Setia's totals and holdings. The dossier adds each equity grant MapLight Therapeutics disclosed for Vishwas Setia and MapLight Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full MapLight Therapeutics compensation record

free company brief
MapLight Therapeutics, Inc. (MPLT) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within MapLight Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MapLight Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MapLight Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Vishwas Setia's compensation dossier